TN2013000202A1 - Spiro-oxindole mdm2 antagonists - Google Patents
Spiro-oxindole mdm2 antagonistsInfo
- Publication number
- TN2013000202A1 TN2013000202A1 TNP2013000202A TN2013000202A TN2013000202A1 TN 2013000202 A1 TN2013000202 A1 TN 2013000202A1 TN P2013000202 A TNP2013000202 A TN P2013000202A TN 2013000202 A TN2013000202 A TN 2013000202A TN 2013000202 A1 TN2013000202 A1 TN 2013000202A1
- Authority
- TN
- Tunisia
- Prior art keywords
- spiro
- mdm2 antagonists
- oxindole mdm2
- antagonists
- oxindole
- Prior art date
Links
- 102000012199 E3 ubiquitin-protein ligase Mdm2 Human genes 0.000 title abstract 2
- 239000005557 antagonist Substances 0.000 title abstract 2
- 101150024228 mdm2 gene Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 108050002772 E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/060300 WO2012065022A2 (fr) | 2010-11-12 | 2011-11-11 | Spiro-oxindoles antagonistes de mdm2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TN2013000202A1 true TN2013000202A1 (en) | 2014-11-10 |
Family
ID=54360702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TNP2013000202A TN2013000202A1 (en) | 2011-11-11 | 2013-05-08 | Spiro-oxindole mdm2 antagonists |
Country Status (1)
| Country | Link |
|---|---|
| TN (1) | TN2013000202A1 (fr) |
-
2013
- 2013-05-08 TN TNP2013000202A patent/TN2013000202A1/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12013500955A1 (en) | Spiro-oxindole mdm2 antagonists | |
| MX346375B (es) | Antagonistas de espiro-oxindol de mdm2. | |
| TN2012000161A1 (en) | Spiro-oxindole mdm2 antagonists | |
| PH12013502565A1 (en) | Substituted imidazopyridinyl-aminopyridine compounds | |
| MX349004B (es) | Nuevos compuestos. | |
| GB201209613D0 (en) | New compounds | |
| GB201118656D0 (en) | New compounds | |
| IN2014MN00986A (fr) | ||
| GB201106743D0 (en) | Novel compounds | |
| GB201106750D0 (en) | Novel compounds | |
| PH12014502406A1 (en) | Anti-il-23p19 antibodies | |
| PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
| MY186311A (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| IN2012MN02591A (fr) | ||
| MX366899B (es) | Nuevos compuestos. | |
| PH12014501991B1 (en) | Phenicol antibacterials | |
| MX349224B (es) | Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa. | |
| PH12014502032A1 (en) | Treatment of brain cancer | |
| EA032271B9 (ru) | Вещества, фармацевтическая композиция и методы применения при лечении воспалительных заболеваний | |
| MX357284B (es) | Compuestos de quinona para tratar enfermedades mediadas por ape1. | |
| MX2016004094A (es) | Composicion farmaceutica que comprende capecitabina y ciclofosfamida. | |
| TN2013000202A1 (en) | Spiro-oxindole mdm2 antagonists | |
| MX2014004742A (es) | Nuevos agentes antibacterianos de fenicol. | |
| TN2013000265A1 (en) | Anti-cd38 antibodies |